We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » California Legislator Joins Calls for Biogen/FDA Investigation Over Aducanumab Approval
California Legislator Joins Calls for Biogen/FDA Investigation Over Aducanumab Approval
Another lawmaker has joined the ranks of those calling for a federal investigation into an allegedly improper collaboration between FDA officials and Biogen to ensure approval of Aduhelm (aducanumab), the first new Alzheimer’s treatment in nearly 20 years.